1) oxcarbazepine
奥卡西平
1.
Clinical assessment of the use of Oxcarbazepine on children with benign epilepsy with centrotemporal spikes;
奥卡西平治疗儿童良性癫癎伴中央颞区棘波的临床观察
2.
Determination of the Concentration of the Metabolite of Oxcarbazepine in Human Blood Plasma with HPLC;
高效液相色谱法测定人血浆奥卡西平代谢产物浓度
3.
Determination of active metabolite of oxcarbazepine by RP-HPLC and study of its pharmacokinetics in Chinese healthy volunteers;
反相-高效液相色谱法测定奥卡西平活性代谢物及其在健康人体的药代动力学特征
2) monohydroxycarbazepine
单羟奥卡西平
1.
A HPLC method was established for the simultaneous determination of phenobarbital, lamotrigine, oxcarbazepine and monohydroxycarbazepine in human plasma.
双波长双通道检测,分别在215nm测定苯巴比妥和单羟奥卡西平,240nm测定拉莫三嗪和奥卡西平。
3) active monohydroxy metabolite
奥卡西平10-单羟基代谢物
1.
Plasma samples were processed by liquid-liquid extraction and active monohydroxy metabolite (MHD), the active metabolite of oxcarbazepine, in plasma were determined by high performance liquid chromatography.
方法10名健康志愿者单剂量口服奥卡西平300mg;血浆样品经液-液萃取,用高效液相色谱法检测奥卡西平10-单羟基代谢物(MHD)。
4) Carbamazepine
[英][,kɑ:bə'mæzəpi:n] [美][,kɑrbə'mæzə,pin]
卡马西平
1.
Dissolution Rate and Bioavailability Comparison of Carbamazepine Tablets from Different Factories;
4家药厂卡马西平片溶出度和生物利用度考察
2.
Electrolysis- Fluorescence Determination of Carbamazepine in Tablet;
电解荧光光度法测定卡马西平的含量
3.
Effect of Platycodon Grandiflorum on the Blood Concentration of Carbamazepine in Rabbits;
桔梗对卡马西平家兔体内血药浓度的影响
5) CBZ
卡马西平
1.
Studies on Fukang Tablets in Resisting Nephotoxicity due to CBZ;
复康片拮抗卡马西平肾毒性的研究
2.
Effect of long-term administration of CBZ on the structure of rat s cerebellum;
长期应用卡马西平对大鼠小脑结构的影响
3.
Aim:to study the preventive effect of Fukang tablet on rat s kidney toxicity induced by Carbamazepine CBZ Methods:A total of 48 rats were randomly allocated into 4 groups;normal Control group was given distilled water,model group,low-dose and high-dose Fukang tablet groups were given CBZ to establish the kidney injury model.
目的:探讨复康片对卡马西平肾脏毒性的预防作用。
6) carbamazepine
[英][,kɑ:bə'mæzəpi:n] [美][,kɑrbə'mæzə,pin]
卡巴西平
补充资料:奥卡西平
分子式:C15H12N2O
分子量:暂无
CAS号:28721-07-5
性质:暂无
制备方法:暂无
用途:神经系统用药。
分子量:暂无
CAS号:28721-07-5
性质:暂无
制备方法:暂无
用途:神经系统用药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条